Literature DB >> 33547906

Upregulation of PTK7 and β-catenin after vaginal mechanical dilatation: an examination of fibulin-5 knockout mice.

Ryo Uemura1, Daisuke Tachibana2, Masayuki Shiota3, Kayo Yoshida4, Kohei Kitada1, Akihiro Hamuro1, Takuya Misugi1, Masayasu Koyama1.   

Abstract

INTRODUCTION AND HYPOTHESIS: Pelvic organ prolapse (POP) in women is associated with deficiency of elastic fibers, and fibulin-5 is known to be a critical protein in the synthesis of elastin. The purpose of this study is to investigate the related pathway for the synthesis of elastin via fibulin-5 using fibulin-5 knockout mice.
METHODS: Fibulin-5 knockout mice were generated using the CRISPR/Cas9 system, and vaginal dilatation was used to mimic vaginal delivery. We divided the mice into three groups: Fbln5+/+ mice immediately after dilatation (Fbln5+/+ day0), Fbln5+/+ mice 3 days after dilatation (Fbln5+/+ day3) and Fbln5-/- mice 3 days after dilatation (Fbln5-/- day3). Proteins related to elastogenesis in the vaginal wall were measured by liquid chromatography mass spectrometry (LC-MS/MS) analysis, and differences in the expression of these proteins between the Fbln5-/- mice and the Fbln5+/+ mice were analyzed using western blotting.
RESULTS: In the LC-MS/MS analysis, protein tyrosine kinase 7 (PTK7) was not detected in the Fbln5-/- day3 group, although the expression increased by > 1.5 times between the Fbln5+/+ day0 and day3 groups. PTK7 and β-catenin are known to act in the Wnt/β-catenin pathway, and both were upregulated after dilatation in the Fbln5+/+ mice, though not in the Fbln5-/- mice.
CONCLUSION: Our findings suggest that these proteins are involved in elastogenesis via fibulin-5, and the impairment of these proteins might be the underlying cause of POP manifestation.
© 2021. The International Urogynecological Association.

Entities:  

Keywords:  Beta-catenin; Elastin; Fibulin-5; Pelvic organ prolapse; Protein tyrosine kinase 7 (PTK7); Wnt

Mesh:

Substances:

Year:  2021        PMID: 33547906     DOI: 10.1007/s00192-021-04693-2

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  17 in total

1.  Reproductive factors, family history, occupation and risk of urogenital prolapse.

Authors:  F Chiaffarino; L Chatenoud; M Dindelli; M Meschia; A Buonaguidi; F Amicarelli; M Surace; E Bertola; E Di Cintio; F Parazzini
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-01       Impact factor: 2.435

2.  Pelvic organ prolapse in fibulin-5 knockout mice: pregnancy-induced changes in elastic fiber homeostasis in mouse vagina.

Authors:  Peter G Drewes; Hiromi Yanagisawa; Barry Starcher; Ian Hornstra; Katalin Csiszar; Spyridon I Marinis; Patrick Keller; R Ann Word
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  The synthesis of soluble and insoluble elastin in chicken aorta as a function of development and age. Effect of a high cholesterol diet.

Authors:  F W Keeley
Journal:  Can J Biochem       Date:  1979-11

Review 4.  Risk factors for prolapse recurrence: systematic review and meta-analysis.

Authors:  Talia Friedman; Guy D Eslick; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2017-09-18       Impact factor: 2.894

Review 5.  Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors.

Authors:  Godfrey J A Walker; Prasanna Gunasekera
Journal:  Int Urogynecol J       Date:  2010-07-09       Impact factor: 2.894

6.  Changes in expression of fibulin-5 and lysyl oxidase-like 1 associated with pelvic organ prolapse.

Authors:  Hyun Joo Jung; Myung Jae Jeon; Ga Won Yim; Sei Kwang Kim; Jong Rak Choi; Sang Wook Bai
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-05-18       Impact factor: 2.435

7.  Fibulin-5 (FBLN5) gene polymorphism is associated with pelvic organ prolapse.

Authors:  Maryam B Khadzhieva; Svetlana V Kamoeva; Anastasya G Chumachenko; Anastasya V Ivanova; Ilya V Volodin; Ivan S Vladimirov; Serikbay K Abilev; Lyubov E Salnikova
Journal:  Maturitas       Date:  2014-05-13       Impact factor: 4.342

8.  One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

Authors:  Haoyi Wang; Hui Yang; Chikdu S Shivalila; Meelad M Dawlaty; Albert W Cheng; Feng Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2013-05-02       Impact factor: 41.582

9.  Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo.

Authors:  Maretoshi Hirai; Tetsuya Ohbayashi; Masahito Horiguchi; Katsuya Okawa; Akari Hagiwara; Kenneth R Chien; Toru Kita; Tomoyuki Nakamura
Journal:  J Cell Biol       Date:  2007-03-19       Impact factor: 10.539

10.  Differential regulation of elastic fiber formation by fibulin-4 and -5.

Authors:  Rawshan Choudhury; Amanda McGovern; Caroline Ridley; Stuart A Cain; Andrew Baldwin; Ming-Chuan Wang; Chun Guo; Aleksandr Mironov; Zoe Drymoussi; Dorothy Trump; Adrian Shuttleworth; Clair Baldock; Cay M Kielty
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

View more
  2 in total

Review 1.  Mouse Knockout Models for Pelvic Organ Prolapse: a Systematic Review.

Authors:  Kristina Allen-Brady; Maria A T Bortolini; Margot S Damaser
Journal:  Int Urogynecol J       Date:  2022-01-28       Impact factor: 1.932

2.  Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.

Authors:  Fredrik Barrenäs; Scott G Hansen; Lynn Law; Connor Driscoll; Richard R Green; Elise Smith; Jean Chang; Inah Golez; Taryn Urion; Xinxia Peng; Leanne Whitmore; Daniel Newhouse; Colette M Hughes; David Morrow; Kurt T Randall; Andrea N Selseth; Julia C Ford; Roxanne M Gilbride; Bryan E Randall; Emily Ainslie; Kelli Oswald; Rebecca Shoemaker; Randy Fast; William J Bosche; Michael K Axthelm; Yoshinori Fukazawa; George N Pavlakis; Barbara K Felber; Slim Fourati; Rafick-Pierre Sekaly; Jeffrey D Lifson; Jan Komorowski; Ewelina Kosmider; Danica Shao; Wenjun Song; Paul T Edlefsen; Louis J Picker; Michael Gale
Journal:  PLoS Pathog       Date:  2021-07-06       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.